Clinical trial reportInternational journal of radiation oncology, biology, physicsPublished
Radiation Quality and Workflow in NRG GY017: Anti-PD-L1 (Atezolizumab) as an Immune Primer or Concurrently With Radiation Therapy for Node-Positive Locally Advanced Cervical Cancer
Regional connection
Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, University of Pennsylvania. Affiliation source
- Institutions
- Thomas Jefferson University, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- International journal of radiation oncology, biology, physics
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Prospective Studies; Uterine Cervical Neoplasms; Female; Radiotherapy, Intensity-Modulated; Workflow; Organs at Risk; Antibodies, Monoclonal, Humanized; Chemoradiotherapy
- PubMed ID
- 42184868
- PubMed Central ID
- PMC13404102
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked